Perfil

Christoph (Chris) Thiemermann is Professor of Pharmacology and Centre Lead for Translational Medicine & Therapeutics at the William Harvey Research Institute (WHRI). He graduated with honours in Medicine (1986), obtained his MD in Medicine (1987, summa cum laude) from the University in Cologne in Germany and received consecutive Fellowships from the Deutsche Forschungsgemeinschaft (DFG) and the Thyssen Foundation (Germany). He joined the WHRI in July 1987, where he obtained a PhD in Pharmacology under the supervision of The Nobel Laureate Sir John Vane in 1991. Thiemermann is a Scientist/Clinician with a strong research track record in cardiovascular disease (acute medicine, renal disease, shock) with a specific expertise in target discovery, pharmacology and translational medicine. Since 2007, he is Centre Lead for Translational Medicine at the WHRI/Barts NHS Trust, (since 2015) Deputy Director of the Centre for Diabetic Kidney Disease at Bart’s NHS Trust, and (since 2012) the Lead for Organ Protection in the Centre for Trauma Sciences at the Royal London Hospital.

Thiemermann has published extensively (Google Scholar: 485 papers with > 37,000-times (h-index=102). His research was recognised by awards of the British Pharmacological Society (Sandoz-Prize, Surgical Infection Society Europe (1999), Menarini-Award for CV Research (2001), Honorary fellowship of the ESS (2019), and Sander Patel Award of the Government of Gujarat (2022). Thiemermann is a Fellow of the Academy of Medical Sciences (UK), a Fellow of the British Pharmacological Society, a Foreign Member of the Academy of Sciences of Lisboa (Portugal), Past-President of the European Shock Society. In 2018, he was awarded the Albert Nelson Lifetime Achievement Award by Who-is-Who publications board for his contributions to pharmacology.

He has significant commercial and drug development experience and (since 1995) is a Director, and since 2003 the Chief Executive Officer of William Harvey Research Limited (www.williamharvey.co.uk), and has organised 25 international conferences (including the John Vane Memorial Conference Series at the Royal Society).